Safe Psilocybin Therapy in Canada

The world’s drug policy is changing rapidly in tandem with the emerging evidence supporting psychedelic-assisted psychotherapy (PAP) for treating a wide range of mental health conditions. Safe Psilocybin Therapy in Canada August 2020, the first Section 56 exemptions were granted for psilocybin therapy in Canada – which had been banned since the 1960s – when four palliative care patients with incurable cancer were approved to receive a session of this treatment.

These participants completed a series of surveys before and two weeks after their sessions, which allowed us to assess changes in several outcomes, including anxiety symptoms, depression, pain levels, fears around COVID-19 and quality of life. We also asked about spiritual well-being, relationships and past trauma. Overall, these results were very promising, demonstrating that psilocybin can have profoundly positive effects in these individuals and may help alleviate end-of-life distress and spiritual malaise.

Experienced Psilocybin Therapists in Toronto: What You Should Know

However, the study also illustrates that these experiences are complex and unique, with each individual likely to experience their own unique benefits and harms. Therefore, we strongly recommend that any individual interested in receiving psilocybin therapy should pursue a clinical trial or Health Canada’s Special Access Program – both of which are existing legal routes for obtaining a controlled substance that have established safeguards to ensure safety, a reliable supply of the drug and practitioner oversight.